This statistic shows the expenditure on research and development of biotech company Amgen in 2012 to 2019 , sorted by category . Amgen is a U.S.-based multinational biopharmaceutical company , headquartered in Thousand Oaks , California . Amgen 's R & D expenses amounted to approximately 4.1 billion U.S. dollars in 2019 . Of that amount , some 1.06 billion U.S. dollars were spent on later stage clinical programs .
